Aclaris Therapeutics, Inc. (ACRS) › Net IncomeAclaris Therapeutics, Inc. (ACRS) — Net IncomeAnnual figures by fiscal year, from SEC filings.2013: -$5.24M2014: -$8.52M2015: -$20.56M2016: -$48.08M2017: -$68.52M2018: -$132.74M2019: -$161.35M2020: -$51.02M2021: -$90.86M2022: -$86.91M2023: -$88.48M2024: -$132.06M2025: -$64.92M-$64.92M2013Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$64.92M+50.8%2024-$132.06M-49.3%2023-$88.48M-1.8%2022-$86.91M+4.4%2021-$90.86M-78.1%2020-$51.02M+68.4%2019-$161.35M-21.6%2018-$132.74M-93.7%2017-$68.52M-42.5%2016-$48.08M-133.8%2015-$20.56M-141.4%2014-$8.52M-62.7%2013-$5.24M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share